| 产品名称 | Imanis Life Sciences | CL192 | K562-Fluc-Puro/HuBCMA-Neo |
|---|---|
| 目录号 | CL192 |
| 别名 | K562-Fluc-Puro/HuBCMA-Neo |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| CL192 | 咨询 | 咨询 |
Imanis Life Sciences | CL192 | K562-Fluc-Puro/HuBCMA-Neo
品名：K562-Fluc-Puro/HuBCMA-Neo
货号：CL192
品牌：Imanis Life Sciences
产品描述
Species：Human
Cell Type：Chronic Myelogenous Leukemia
Transgene：Firefly luciferase (Fluc; Luc2)Human B cell maturation antigen (HuBCMA)
Selection Gene：Puromycin resistance (Puro)Neomycin resistance (Neo)
The K562-Fluc-Puro/HuBCMA-Neo cell line stably expresses firefly luciferase and human BCMA. The cells are designed for in vitro and in vivo studies of BCMA. Parental K562-Fluc-Puro cells can be used as a negative control. Parental K562-Fluc-Puro cells (Imanis #CL171) cells were transduced with a human BCMA-encoding lentivirus. A high HuBCMA expressing population was generated by selection using a methylcellulose based semi-solid medium. This cell line has been tested for mycoplasma contamination and is certified mycoplasma free. The parental K562 cell line was licensed and purchased directly from ATCC*. *The ATCC trademark and trade name and any and all ATCC catalog numbers are trademarks of the American Type Culture Collection.
